Cynthia E. Fisher, MD, MPH | Allergy and Infectious Diseases

Associate Professor

Department of Medicine, Division of Allergy & Infectious Diseases

Research Associate

Vaccine & Infectious Disease Division (VIDD), Fred Hutchison Cancer Researcher Center

Faculty Information

Biography

Dr. Fisher specializes in the research and treatment of infectious diseases in organ transplant recipients and cancer patients. Specific areas of investigation include risk factors, prevention, diagnosis, and treatment of invasive fungal infections and respiratory viral infections. She also focuses on identifying underlying genetic factors that predispose patients to develop severe infections following transplantation.

Education & Training:

MPH

John Hopkins Bloomberg, School of Public Health

Baltimore MD

2006

John Hopkins Bloomberg, School of Public Health

Baltimore MD

2007

Residency

University of Pennsylvania

Philadelphia, PA

2007-2010

Fellowship in Infectious Diseases

University of Washington

Seattle WA

2010-2013

Honors:

Phi Beta Kappa

2001

Merck Index Award, Top Chemistry/Biochemistry student at University of Washington

2002

O.C. Hubert Fellow in International Health, Centers of Disease Control

2006

Travel Grant, Infectious Disease Society of America

2012

Contact

Email:

celaine@uw.edu

Phone:

(206) 598-9149

Mailing Address:

1959 NE Pacific St.

Box 356174

Seattle, WA 98195

Publications

PubMed:

PubMed Bibliography

Publications:

Seo S, Renaud C, Kuypers JM, Chiu CY, Huang M, Samayoa E, Xie H, Yu G, Fisher CE, Gooley T, et al. Idiopathic pneumonia syndrome after hematopoietic cell transplantation: Evidence of occult infectious etiologies. Blood. 2015 Jun 11; 125(24):3789-97.
•PubMed Abstract

Preiksaitis CM, Kuypers JM, Fisher CE, Campbell AP, Jerome KR, Huang ML, Boeckh M, Limaye AP. A patient self-collection method for longitudinal monitoring of respiratory virus infection in solid organ transplant recipients. J Clin Virol. 2015; 62:98-102.
• PubMed Abstract

Fisher CE, Stevens AM, Leisenring W, Pergam SA, Boeckh M, Hohl TM. Independent contribution of bronchoalveolar lavage and serum galactomannan in the diagnosis of invasive pulmonary aspergillosis. Transplant Infect Dis. 2014 Jun; 16(3):505-10.
•PubMed Abstract

Fisher CE, Stevens AM, Boeckh M, Leisenring W, Pergam S, Hohl T. Degree of positivity of serum galactomannan is associated with higher mortality in HCT patients with invasive aspergillosis. Clin Infect Dis. 2013 Oct 1; 57(7):1001–1004.
•PubMed Abstract

Printer-friendly